PERSPECTA

News from every angle

← Back to headlines

Tango Therapeutics Rises After Q4 Results and Clinical Pact

Tango Therapeutics saw its stock rise following the release of its fourth-quarter results and the announcement of a clinical partnership with Erasca.

5 Mar, 18:46 — 5 Mar, 18:46
PostShare
Only 1 source covers this story